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Therefore, we investigated oxidative stress levels in AMI patients
with lipophilic atorvastatin or hydrophilic pravastatin. Methods and
results: The study population included a prospective, randomized,
open-label, study in AMI patients within ALPS-AMI study. Patients that
have undergone successful percutaneous coronary intervention will be
randomly allocated to receive either atorvastatin or pravastatin with the
treatment goal of lowering their low-density lipoprotein-cholesterol
level below 100mg/dl for 2 years. Diacron-reactive oxygen metabolite
(dROM) and biological antioxidant potential (BAP) levelsweremeasured
in AMI patients with lipophilic (atorvastatin, n = 38) and hydrophilic
(pravastatin, n = 36) statin therapy on admission (dROM: 395.5 ± 37.5
vs. 392.1 ± 35.6 Carratelli units (U. Carr) (p= 0.37), BAP: 2756.3 ± 75.2
vs. 2849.1 ± 71.6 mmol/l (p = 0.39), respectively) and 6, 12, and
24 months (24 months: dROM: 374.5 ± 41.5 vs. 381.1 ± 37.6 U. Carr
(p= 0.28), BAP: 2957.3 ± 135.9 vs. 2941.5 ± 121.3 mmol/l (p= 0.48),
respectively). Conclusion: This is the ﬁrst clinical trial to compare the
effects of lipophilic and hydrophilic statin therapy on oxidative stress
levels and no difference was noted in oxidative stress levels between
lipophilic and hydrophilic statin therapy in patients with AMI during the
follow-up period.
doi:10.1016/j.lfs.2014.01.050
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Obesity is associated with higher risk of premature death due to
metabolic and cardiovascular abnormalities. One third of obese
individuals, however, have a “metabolically healthy” phenotype and it
is debated whether this status carries lower cardiovascular risk than its
metabolically unhealthy counterpart. Given the role of the endothelin
(ET)-1 system in the development of obesity-related vascular dysfunc-
tion, we investigated whether differences exist in ET-1-dependent
vasoconstrictor activity between the divergent obesity subphenotypes.
To this end, we compared vasodilator responses (strain-gauge plethys-
mography) to intra-arterial infusion of the selective ETA receptor
blocker BQ-123 (10 nmol/min for 60 min) in healthy subjects (n = 31)
and obese patients (n= 38); obese patients were divided in two
subgroups according to the absence (n= 11) or presence (n= 27) of
any of the glucose or lipid abnormalities characteristic of the metabolic
syndrome (MetS; ATP III criteria). The vasodilator response to BQ-123
was greater in obese than in lean subjects (P b 0.001), whereas no
difference was observed in the response to BQ-123 between metabol-
ically healthy and unhealthy obese patients (P N 0.05). Similarly, BQ-
123-induced vasodilation was related to the number of MetS compo-
nent in the whole population (P = 0.008), but not within the obese
group (P N 0.05). In the whole population, body mass index and mean
arterial pressure were signiﬁcant determinants of the response to BQ-
123 (r = 0.46 and r = 0.42, respectively; both P b 0.001), whereas no
correlation was observed between BQ-123-induced vasodilation and
either plasma glucose, triglycerides or HDL-cholesterol levels (all
P N 0.05). In conclusion, ET-1-dependent vasoconstrictor tone is higher
in obese patients than in their lean counterpart, but this defect is not
inﬂuenced by the presence of obesity-related metabolic abnormalities.
doi:10.1016/j.lfs.2014.01.051
Epigallocatechin gallate attenuates ET-1-induced contraction in
carotid and thoracic aorta from type 2 diabetic OLETF rat
Takayuki Matsumoto, Shun Watanabe,
Ryusuke Kawamura, Tsuneo Kobayashi
Department of Physiology andMorphology, Institute of Medicinal Chemistry,
Hoshi University, Tokyo, Japan
E-mail address: t-matsu@hoshi.ac.jp (T. Matsumoto)
There is a growing body of evidence suggested that epigallocate-
chin gallate (EGCG), a major catechin isolated from green tea, has
several beneﬁcial effects such as anti-oxidant and anti-inﬂammatory
activities. However, whether treatment with EGCG could suppress the
ET-1-induced contraction in large arteries from type 2 diabetic rats is
unknown. We hypothesized that long-term treatment with EGCG
would attenuate the ET-1-induced contractions in type 2 diabetic
arteries. To test this hypothesis, Otsuka Long–Evans Tokushima fatty
(OLETF) rats (43 weeks old)were treatedwith EGCG (200 mg/kg/day for
2 months, p.o.) and contractile/relaxant responses to ET-1, phenyleph-
rine (PE), acetylcholine (ACh) and sodium nitroprusside (SNP) in the
presence and absence of endotheliumweremeasured in common carotid
artery (CA) and thoracic aorta (TA) from EGCG-treated and -untreated
OLETF rats and control Long–Evans Tokushima Otsuka (LETO) rats. In
OLETF rats, EGCG attenuated sensitivity to ET-1 in CA [pD2, EGCG-
treated: 7.95 ± 0.07 vs. -untreated: 8.15 ± 0.06 (p b 0.05)] and TA [pD2,
EGCG-treated: 7.98 ± 0.08 vs. -untreated: 8.24 ± 0.06 (p b 0.05)] com-
pared to untreated groups. However, EGCG did not alter PE-induced
contractions in both arteries from OLETF rats. In the endothelium-
denuded arteries, EGCG did not affect ET-1- and PE-induced contractions
in both OLETF and LETO groups. ACh-induced relaxations were increased
by EGCG treatment in CA and TA from OLETF group. SNP-induced
relaxations were similar between EGCG-treated and -untreated groups.
Our data suggest that within the timescale investigated here, EGCG
attenuates ET-1-induced contractions in large arteries from type 2
diabetic rats and one of the mechanisms may be attributable to
normalizing endothelial function.
doi:10.1016/j.lfs.2014.01.052
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Background and objective: Previous studies have described an
association between kidney diseases and endothelin. Primary ne-
phrotic syndrome (NS) is the common renal disease in children. The
aim of this study was to determine whether polymorphisms in the
endothelin-A receptor gene might be associated with the morbidity
and the steroid response of primary nephrotic syndrome in children.
Methods: 53 children with primary nephrotic syndrome as case group
were subdivided into steroid resistance NS group and non-steroid
resistance NS group; hypertension group and non-hypertension
group. 50 healthy children were as control group. All subjects were
genotyped for endothelin-A receptor polymorphisms in locus
rs10305936 (in exon 8 of the EDNRA) by using the polymerase chain
reaction and direct gene sequence test technique. Results: (1) There is
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an adenine insertion in locus rs10305936. The frequencies of A
homozygote, A heterozygote and no insertion genotype on case group
and control group were 7.5%, 81.1%, and 11.3% and 0%, 98.0%, and 2.0%
respectively, and the difference between these two groups were of
statistical signiﬁcance (&chi2 = 7.88, P = 0.019). (2) There were no
statistically signiﬁcant differences in genotypewithin steroid resistant
NS group and non-steroid resistant NS group and hypertension group
and non-hypertension group (P N 0.05). Conclusions: There is an
adenine insertion in locus rs10305936. The endothelin-A receptor
gene polymorphisms in locus rs10305936 are related to the morbidity
of nephrotic syndrome in children.
doi:10.1016/j.lfs.2014.01.053
Serum endothelin-1 and big endothelin-1 in patients with chronic
thromboembolic pulmonary hypertension can be markers to
predict hemodynamics after balloon pulmonary angioplasty
Kazuya Miyagawaa, Kazuhiko Nakayamaa,b, Yoko Suzukib,
Yu Taniguchia, Hiroto Kinutania, Toshiro Shinkea,
Ken-ichi Hirataa, Noriaki Emotoa,b
aDivision of Cardiovascular Medicine, Department of Internal Medicine,
Kobe University Graduate School of Medicine, Japan
bClinical Pharmacy, Kobe Pharmaceutical University, Japan
E-mail address: miyagawa@med.kobe-u.ac.jp (K. Miyagawa)
Backgrounds: Chronic thromboembolic pulmonary hypertension
(CTEPH) is characterized by stenosis and obstruction of pulmonary
artery with non-resolving organized thromboemboli, leading to
elevated pulmonary vascular resistance (PVR) and right heart failure.
Endothelin (ET) system is closely correlated with the hemodynamic
severity in patients with CTEPH, and serum ET-1 level can be a
marker to predict clinical outcome. Recently, balloon pulmonary
angioplasty (BPA) for non-operable CTEPH patients is establishing.
Our objective was to study the dynamics of ET system by measuring
serum ET-1 and big ET-1 levels in CTEPH patients who underwent BPA
and assess the relationship between ET system and hemodynamics with
orwithout ET receptor antagonists (ERAs).Methods: BPAwas performed
on thirteen patients diagnosed as non-operable CTEPH (22 sessions;
baseline mean pulmonary arterial pressure, 36.1 ± 9.9 mmHg; cardiac
index (C.I.), 2.44 ± 0.56 l/min/m2; medical therapy with ERAs, 50%).
Samples were collected before and after BPA from radial artery and
pulmonary artery. SerumET-1 and big ET-1 levels weremeasured using
enzyme-linked immunosorbent assay and analyzedwith hemodynamic
data measured by right heart catheterization. Results: At baseline, not
only serum ET-1 but also big ET-1 levels were higher in ERA group than
in non-ERA group. ET-1 and big ET-1 levels were signiﬁcantly increased
after BPA and decreased to baseline levels in about one week. In ERA
group, C.I. post BPA was higher than that in non-ERA group and
signiﬁcantly and strongly correlated with ET-1 and big-ET-1 levels.
Conclusions: Elevated serum ET-1 and big ET-1 levels in CTEPH patients
with ERAs can be markers to predict better hemodynamics after BPA.
doi:10.1016/j.lfs.2014.01.054
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Purpose: To evaluate whether BQ788 has beneﬁcial action on
the septic brain. Methods: We prepared the raw fecal ﬂuid from
soft stool of mice. C57BL/6J mice were randomly divided into
three groups as follows: pre-PBS + raw fecal ﬂuid group (Fresh
group); pre-BQ788 + raw fecal ﬂuid group (BQ group); and pre-
BQ788 + PBS group (PBS group). According to each experimental
condition, PBS or BQ788 was intravenously injected to mice prior to
the i.p. administration of the fecal ﬂuid or PBS. All groups of mice
were sacriﬁced at 8 h after administration, and then the brain and
peripheral blood samples were prepared. Results: In Fresh group, an
enhanced expression of c-FOS was observed in the paraventricular
nucleus of both the thalamus and hypothalamus, and an increase
of apoptotic neuroblasts was determined in the SGZ of the dentate
gyrus, compared with PBS group. In the corresponding region
to their ﬁndings, the number of reactive microglia and vascular
permeability were markedly increased. BQ788 inhibited the induc-
tion of c-FOS expression, neuroblast apoptosis and reactive microglia
without affecting the vascular leakage. Furthermore, western blot
array analysis of peripheral blood from each group showed that various
proinﬂammatory cytokines were elevated like a cytokine storm in the
serum from Fresh group. This typical induction of cytokines was
insensitive to the treatment with BQ788. Discussion: In the present
study, we demonstrated that BQ788 could protect the brain from sepsis-
associated pathophysiological inputs as follows: neural cell death,
inﬂammatory response and the Hans Selye's environmental stress
reaction. We will discuss the mode of action of BQ788 in the brain.
doi:10.1016/j.lfs.2014.01.055
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Endothelin (ET)-1 plays a role as a pro-inﬂammatory mediator
and a marker of endothelial dysfunction and is known to be involved
in the pathogenesis of acute lung injury (ALI). Systemic administra-
tion of some ET receptor antagonists (ETRAs) has been beneﬁcial
in various experimental ALI cases, particularly in sepsis-induced
models. However, there are few studies to assess whether intra-
tracheal administration of ETRAs has therapeutic beneﬁt in ALI
models caused by pulmonary disease. Likewise, the relationships
between ET signaling and production of proinﬂammatory cytokines
in the pathogenesis of ALI are still unknown. To determine whether
intratracheal administration of ETRAs has anti-inﬂammatory effect
on pulmonary inﬂammation in vivo, we induced ALI in mice by
intratracheal instillation of LPS in combination with BQ123 or BQ788.
Then, we examined lung histopathological changes and differential
cell counts and a comprehensive cytokine expression proﬁle in
bronchoalveolar lavage ﬂuid (BALF) from mice 12 h after LPS
instillation with or without the drugs. The LPS-induced neutrophilic
inﬁltration into alveoli was inhibited by both BQ123 and BQ788.
Accordingly, a marked increase of total cell count and segmented
neutrophil content in BALF from mice challenged with LPS was
signiﬁcantly inhibited by the BQs. LPS induced several cytokines as
follow, IL-6, G-CSF, sTNFRs, RANTES and so on, which were inhibited
by the BQs. These results suggest that intratracheal administration
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